92 results match your criteria: "ICMR-National Institute of Immunohaematology[Affiliation]"
Ann Hematol
October 2023
Department of Cytogenetics, ICMR-National Institute of Immunohaematology, 13th floor, New Multi-storeyed building, KEM hospital Campus, Parel, Mumbai, Maharashtra, 400012, India.
Congenital amegakaryocytic thrombocytopenia (CAMT) is a rare, genetic, autosomal recessive disorder characterized by severe thrombocytopenia, due to inefficient bone marrow megakaryopoiesis eventually leading to aplasia. Majority of the cases are due to homozygous or compound heterozygous mutations in MPL gene encoding for thrombopoietin (THPO) receptor protein. CAMT can be diagnosed at early phase of life, with major complication of transfusion dependency and hematopoietic transplantation as only curative treatment.
View Article and Find Full Text PDFExpert Rev Hematol
November 2023
ICMR-National Institute of Immunohaematology, King Edward Memorial Hospital, Mumbai, India.
Background: Hydroxyurea (HU) therapy improves the clinical severity of patients with hemoglobinopathies. Few studies have documented some mechanisms of HU, but the exact mechanism of action is unknown. Phosphatidylserine on erythrocytes is responsible for apoptosis.
View Article and Find Full Text PDFJ Infect Public Health
July 2023
Department of Transfusion Transmitted Disease, ICMR-National Institute of Immunohaematology, 13th Floor, New MS Building, KEM Hospital Campus, Parel, Mumbai 400 012, India. Electronic address:
Introduction: Hepatitis B virus (HBV) is global health problem. Family members of HBV infected people are considered as high-risk groups due to frequent household transmission of HBV among contacts of HBsAg carriers. The present study aimed to investigate the intrafamilial transmission of HBV among family members of HBV-infected persons and to identify the risk factors for viral transmission in these setting.
View Article and Find Full Text PDFBr J Haematol
July 2023
Department of Paediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), Mumbai, India.
Indian J Tuberc
April 2023
ICMR-National Institute of Immunohaematology, K. E. M. Hospital, Parel, Mumbai, India.
Immunohematology
April 2023
PhD, Scientist E, HOD Transfusion Medicine, ICMR-National Institute of Immunohaematology, 13th Floor, New Multistoryed Building, KEM Hospital Campus, Parel, Mumbai, Maharashtra 400012, India.
Complexities of D within the Rh blood group system have long been recognized, initially using basic serologic testing and, more recently, using advanced and sensitive typing reagents. Discrepancies may arise when an individual carries a D antigen showing altered D antigen expression. These D variants are clinically important, since they may lead to production of anti-D in the carrier and induce alloimmunization in D- recipients, making their correct identification imperative.
View Article and Find Full Text PDFCancer Genet
June 2023
ICMR - National Institute of Immunohaematology, 13th floor, New multistoried building, K.E.M Hospital campus, Parel, Mumbai, 400012, India.. Electronic address:
The sole t(8;22)(p11.2;q11.2)/BCR- FGFR1 chromosomal abnormality formerly known as aCML is an extremely rare disease entity with a history of rapid progression.
View Article and Find Full Text PDFInt J Pharm
March 2023
Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, N. P. Marg, Matunga, Mumbai 400019, Maharashtra, India. Electronic address:
In this study we present pH-responsive rifampicin (RIF) microparticles comprising lecithin and a biodegradable hydrophobic polymer, polyethylene sebacate (PES), to achieve high intramacrophage delivery and enhanced antitubercular efficacy. PES and PES-lecithin combination microparticles (PL MPs) prepared by single step precipitation revealed average size of 1.5 to 2.
View Article and Find Full Text PDFBiomedicines
January 2023
Pediatric Immunology & Leukocyte Biology Department, ICMR-National Institute of Immunohaematology, Parel, Mumbai 400012, India.
Hepatitis B infection is a major public health problem globally leading to chronic liver disease and death, which are influenced by various environmental and host factors including serum 25-hydroxy-vitamin D levels. There is no comprehensive systematic review reporting the association of serum 25-hydroxy-vitamin D levels and different stages of chronic hepatitis B. This study aimed to analyze the association of 25-hydroxy-vitamin D levels in chronic hepatitis B with various determinants and outcomes.
View Article and Find Full Text PDFIndian J Med Res
August 2022
Department of Paediatric Immunology & Leukocyte Immunology, ICMR-National Institute of Immunohaematology, Mumbai, Maharashtra, India.
Background & Objectives: Sickle cell disease (SCD) constitutes frequently inherited haemoglobin disorders and poses a significant health burden in India. Hydroxyurea (HU), the most commonly used drug, has shown promising results in the clinical management of SCD. The present systematic review was undertaken to assess the efficacy and toxicity of HU in Indian sickle cell patients.
View Article and Find Full Text PDFJ Family Med Prim Care
October 2022
ICMR- National Institute of Immunohaematology (NIIH), KEM Hospital Campus, Mumbai, Maharashtra, India.
Objectives: The Omicron variant-mediated COVID-19 wave is responsible for a global tsunami of cases. There is scarce data about the clinical and epidemiological characteristic analyses of the third wave. We present the data of COVID-19 patients from Mumbai region during the early third wave by taking S-gene target failure (SGTF) as a proxy for probable Omicron cases.
View Article and Find Full Text PDFSci Rep
January 2023
ICMR-National Institute of Immunohaematology, 13th Floor NMS Building, KEM Hospital Campus, Parel, Mumbai, 400012, India.
J Lifestyle Med
May 2022
Homi Bhabha Cancer Hospital/Madan Mohan Malviya Cancer Centre, Varanasi, Uttar Pradesh, India.
Background: Non-communicable disease (NCD) is the leading cause of death, accounting for 70% of total death globally, and posing a major public health challenge. In India, nearly 5.8 million people (WHO report, 2015) die from NCDs every year.
View Article and Find Full Text PDFIndian J Med Res
November 2022
Department of Haemostasis and Thrombosis, ICMR-National Institute of Immunohaematology, Mumbai, Maharashtra, India.
Background & Objectives: During the COVID-19 pandemic it was important to assess the antibody profile in individuals vaccinated with Covaxin (BBV152) and Covishield (ChAdOx1 nCoV-19) with both 28 and 84 days gaps between two doses, those infected with SARS-CoV-2 and post-COVID-19-infected individuals vaccinated with only one dose of either of the vaccines. The present study was aimed to assess these objectives.
Methods: Fifty real time reverse transcription-polymerase chain reaction (qRT-PCR)-confirmed COVID-19-infected individuals, along with 90 COVID-19-naïve (BBV152 and ChAdOx1 nCov-19)-vaccinated individuals, were included in the study.
J Clin Immunol
November 2022
Department of Inborn Errors of Immunity, Bai Jerbai Wadia Hospital for Children, Mumbai, India.
The energy metabolism of myeloid cells depends primarily on glycolysis. 1,5-Anhydroglucitol (1,5AG), a natural monosaccharide, is erroneously phosphorylated by glucose-phosphorylating enzymes to produce 1,5-anhydroglucitol-6-phosphate (1,5AG6P), a powerful inhibitor of hexokinases. The endoplasmic reticulum transporter (SLC37A4/G6PT) and the phosphatase G6PC3 cooperate to dephosphorylate 1,5AG6P.
View Article and Find Full Text PDFHematology
December 2022
Department of Pediatric Immunology and Leukocyte Biology, ICMR- National Institute of Immunohaematology, Parel, Mumbai, India.
Objectives: LPS-responsive beige-like anchor protein (LRBA) deficiency abolishes LRBA protein expression due to biallelic mutations in the LRBA gene that lead to autoimmune manifestations, inflammatory bowel disease, hypogammaglobulinemia in early stages, and variable clinical manifestations.
Materials And Methods: Mutational analysis of the gene was performed in Indian patients using targeted Next Generation Sequencing (t-NGS) and confirmed by Sanger sequencing using specific primers of exons 53. Then, bioinformatics analysis and protein modeling for the novel founded mutations were also performed.
Front Med (Lausanne)
February 2022
Department of Haematogenetics, Indian Council of Medical Research (ICMR)-National Institute of Immunohaematology, Mumbai, India.
Sickle cell disease (SCD) poses considerable public health problems in India. This study was undertaken to understand the clinical course of SCD among children identified during newborn screening programmes in Gujarat and Madhya Pradesh where the frequency of the HbS gene is high. A total of 8,916 newborn babies 8,411 from Gujarat and 505 from Madhya Pradesh were screened over 6 years (2010-2016) using HPLC and the diagnosis was confirmed by molecular analysis in a subset.
View Article and Find Full Text PDFBr J Haematol
May 2022
ICMR-National Institute of Immunohaematology, K.E.M. Hospital campus, Parel, Mumbai, India.
Front Med (Lausanne)
January 2022
ICMR- National Institute of Immunohaematology, KEM Hospital Campus, Mumbai, India.
Type 3 Von Willebrand Disease (VWD) is the least common but the most severe form of a disease, with a prevalence of about 0. 5 to 1 per million in Western countries. The prevalence of type 3 VWD in the developing countries, with a high degree of consanguinity, is about 6 per million.
View Article and Find Full Text PDFHum Immunol
April 2022
CSIR-Institute of Genomics and Integrative Biology, New Delhi 110025, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh 201002, India. Electronic address:
X-linked agammaglobulinemia (XLA) is an X-linked recessive primary immunodeficiency disorder caused due to a pathogenic variant in the Bruton tyrosine (BTK) gene with an incidence of 1:379,000 live births and 1:190,000 male births. Patients affected with XLA present with recurrent infections of the gastrointestinal and respiratory tracts. Here we report the first case series of 17 XLA patients of 10 South Indian families with a wide spectrum of clinical and genetic features.
View Article and Find Full Text PDFMol Biol Rep
March 2022
Department of Haematogenetics, ICMR-National Institute of Immunohaematology, Indian Council of Medical Research, 13th Floor, New Multi-Storeyed Building, King Edward Memorial (KEM.) Hospital Campus, Parel, Mumbai, 400012, India.
Background: Methemoglobin is the reduced form of haemoglobin that is normally found in the blood in levels < 1%. Methemoglobinemia can occur as a congenital or acquired disease. Two types of recessive congenital methaemoglobinemia (RCM) are caused by the NADH-dependent cytochrome b5 reductase enzyme deficiency of the CYB5R3 gene.
View Article and Find Full Text PDFHaemophilia
March 2022
Department of Haematology, Sahyadri Specialty Hospitals, Pune, India.
Introduction: von Willebrand disease (VWD) is the common bleeding disorder with a clinically relevant bleeding prevalence of 1:10,000. von Willebrand disease patients lack both von Willebrand factor (VWF) and factor VIII (FVIII), which are critical for normal haemostasis. The conventional treatment for VWD includes desmopressin and replacement therapy with plasma derived FVIII with VWF concentrates or recombinant VWF.
View Article and Find Full Text PDFSci Rep
October 2021
Department of Haematogenetics, ICMR-National Institute of Immunohaematology, 13th Floor NMS Building, KEM Hospital Campus, Parel, Mumbai, 400012, India.
Hemoglobinopathies though a monogenic disorder, show phenotypic variability. Hence, understanding the genetics underlying the heritable sub-phenotypes of hemoglobinopathies, specific to each population, would be prognostically useful and could inform personalized therapeutics. This study aimed to evaluate the role of genetic modifiers leading to higher HbF production with cumulative impact of the modifiers on disease severity.
View Article and Find Full Text PDFIndian Dermatol Online J
September 2021
Department of Dermatology, Venereology and Leprosy, Seth G.S. Medical College and KEM Hospital, Parel, Mumbai, Maharashtra, India.
Context: Enzyme-linked immunosorbent assay (ELISA) for BP 180 and 230 antibodies is commonly done in patients with bullous pemphigoid. We could not find much data regarding the usefulness of this test to predict the disease severity in Indian population.
Aims: We studied the correlation of IgG anti BP180 and anti BP230 antibody titer with disease severity and clinical features in bullous pemphigoid.
Immunohematology
September 2021
Lions Blood Bank , New Delhi , India .
The In antigen of the Indian blood group system is a high-prevalence antigen. The presence of alloanti-In in a recipient may pose a problem in finding compatible blood for transfusion. The aim of this study was to screen blood donors for In and to include individuals found to be In(b-) in our rare donor registry.
View Article and Find Full Text PDF